Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -23943.00x is 352% below its 3-year average of -5295.93x, near the low end of its 3-year range (-23943.00x–-1072.62x).
As of the fiscal period ended Thursday, June 30, 2022. 75.19% below its 12-month average of -13666.50x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2022 (2022-06-30): -23943.00x.
INTEREST COVERAGE RATIO
-23943.00x
INTEREST COVERAGE RATIO AVG TTM
-13666.50x
INTEREST COVERAGE RATIO AVG 3Y
-5999.81x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-75.19%
CURRENT VS 3Y AVG
-299.06%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-375476.47%
vs the sector median at left
Vaxcyte, Inc.
Market Cap
$9.61B
Interest Coverage Ratio
-23943.00x
TTM Avg
-13666.50x
3Y Avg
-5999.81x
5Y Avg
N/A
Market Cap
$9.63B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$9.66B
Interest Coverage Ratio
5.05x
TTM Avg
5.30x
3Y Avg
10.04x
5Y Avg
14.14x
Market Cap
$9.87B
Interest Coverage Ratio
2.57x
TTM Avg
2.57x
3Y Avg
27.60x
5Y Avg
20.53x
Market Cap
$9.93B
Interest Coverage Ratio
5.52x
TTM Avg
5.51x
3Y Avg
7.63x
5Y Avg
62.06x
Market Cap
$9.33B
Interest Coverage Ratio
5.94x
TTM Avg
6.59x
3Y Avg
5.07x
5Y Avg
3.90x
Market Cap
$10.03B
Interest Coverage Ratio
53.24x
TTM Avg
48.24x
3Y Avg
40.33x
5Y Avg
37.20x
Market Cap
$9.21B
Interest Coverage Ratio
3.91x
TTM Avg
4.60x
3Y Avg
15.68x
5Y Avg
18.14x
Market Cap
$10.15B
Interest Coverage Ratio
-2.28x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vaxcyte, Inc. (PCVX) | $9.61B | -23943.00x | -13666.50x | -5999.81x | N/A |
| Krystal Biotech, Inc. (KRYS)vs › | $9.63B | N/A | N/A | N/A | N/A |
| Henry Schein, Inc. (HSIC)vs › | $9.66B | 5.05x | 5.30x | 10.04x | 14.14x |
| Repligen Corporation (RGEN)vs › | $9.87B | 2.57x | 2.57x | 27.60x | 20.53x |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.93B | 5.52x | 5.51x | 7.63x | 62.06x |
| Insulet Corp. (PODD)vs › | $9.33B | 5.94x | 6.59x | 5.07x | 3.90x |
| The Ensign Group, Inc. (ENSG)vs › | $10.03B | 53.24x | 48.24x | 40.33x | 37.20x |
| Bruker Corporation (BRKR)vs › | $9.21B | 3.91x | 4.60x | 15.68x | 18.14x |
| ImmunityBio, Inc. (IBRX)vs › | $10.15B | -2.28x | N/A | N/A | N/A |
| Align Technology, Inc. (ALGN)vs › | $10.13B | N/A | 67.41x | 66.08x | 407.22x |
Interest Coverage
-23943.0x
Debt/Equity
0.04
Current Ratio
5.72
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2022-06-30 | -23943.00x |
| 2021-06-30 | -3390.00x |
| 2020-03-31 | -3942.29x |
| 2019-12-31 | -2262.71x |
| 2019-09-30 | -1348.89x |
| 2019-06-30 | -1112.00x |
| 2019-03-31 | -1072.62x |
